Rajiv Tandon

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. doi request reprint World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
    Rajiv Tandon
    University of Florida, Tallahassee, USA
    Schizophr Res 100:20-38. 2008
  2. ncbi request reprint Should overeating and obesity be classified as an addictive disorder in DSM-5?
    Claudia Moreno
    University of Florida College of Medicine, Department of Psychiatry, Gainesville, FL 32611, USA
    Curr Pharm Des 17:1128-31. 2011
  3. doi request reprint Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness?
    Rajiv Tandon
    Department of Psychiatry, University of Florida Medical School, Gainesville, FL 32610 3424, USA
    Asian J Psychiatr 6:330-2. 2013
  4. doi request reprint The nosology of schizophrenia: toward DSM-5 and ICD-11
    Rajiv Tandon
    Department of Psychiatry, University of Florida, PO Box 103424, Gainesville, FL 32610 3424, USA
    Psychiatr Clin North Am 35:557-69. 2012
  5. doi request reprint Antipsychotics in the treatment of schizophrenia: an overview
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32610 3424, USA
    J Clin Psychiatry 72:4-8. 2011
  6. doi request reprint Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future
    Rajiv Tandon
    University of Florida, Department of Psychiatry, FL, USA
    Schizophr Res 122:1-23. 2010
  7. ncbi request reprint Defining and measuring clinical effectiveness in the treatment of schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Psychiatr Serv 56:273-82. 2005
  8. doi request reprint Schizophrenia, "just the facts" 4. Clinical features and conceptualization
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, P O Box 100256, Gainesville, FL 32610, USA
    Schizophr Res 110:1-23. 2009
  9. ncbi request reprint Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Mississippi Medical Center, Jackson, Miss, USA
    J Clin Psychiatry 63:12-20. 2002
  10. ncbi request reprint Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
    Rajiv Tandon
    Department of Psychiatry Adjunct, University of Florida, Gainesville, FL, USA
    Psychiatry Res 136:211-21. 2005

Detail Information

Publications13

  1. doi request reprint World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
    Rajiv Tandon
    University of Florida, Tallahassee, USA
    Schizophr Res 100:20-38. 2008
    ....
  2. ncbi request reprint Should overeating and obesity be classified as an addictive disorder in DSM-5?
    Claudia Moreno
    University of Florida College of Medicine, Department of Psychiatry, Gainesville, FL 32611, USA
    Curr Pharm Des 17:1128-31. 2011
    ..In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue...
  3. doi request reprint Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness?
    Rajiv Tandon
    Department of Psychiatry, University of Florida Medical School, Gainesville, FL 32610 3424, USA
    Asian J Psychiatr 6:330-2. 2013
    ..DSM-5 changes in criteria A should have a negligible effect on the prevalence of schizophrenia, with over 98% of individuals with DSM-IV schizophrenia continuing to receive a DSM-5 diagnosis of schizophrenia in this dataset. ..
  4. doi request reprint The nosology of schizophrenia: toward DSM-5 and ICD-11
    Rajiv Tandon
    Department of Psychiatry, University of Florida, PO Box 103424, Gainesville, FL 32610 3424, USA
    Psychiatr Clin North Am 35:557-69. 2012
    ....
  5. doi request reprint Antipsychotics in the treatment of schizophrenia: an overview
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32610 3424, USA
    J Clin Psychiatry 72:4-8. 2011
    ....
  6. doi request reprint Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future
    Rajiv Tandon
    University of Florida, Department of Psychiatry, FL, USA
    Schizophr Res 122:1-23. 2010
    ..We evaluate the potential contribution of pharmacogenomics and other biological markers in optimizing individual treatment and outcome in the future...
  7. ncbi request reprint Defining and measuring clinical effectiveness in the treatment of schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Psychiatr Serv 56:273-82. 2005
    ..This report describes an approach to define and measure the clinical effectiveness of treatment in achieving these objectives...
  8. doi request reprint Schizophrenia, "just the facts" 4. Clinical features and conceptualization
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, P O Box 100256, Gainesville, FL 32610, USA
    Schizophr Res 110:1-23. 2009
    ..Possible implications for DSM-V and ICD-11 definitions of schizophrenia are discussed...
  9. ncbi request reprint Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Mississippi Medical Center, Jackson, Miss, USA
    J Clin Psychiatry 63:12-20. 2002
    ..This article will review the clinical trials examining the efficacy, safety, and tolerability of quetiapine in the treatment of patients with schizophrenia...
  10. ncbi request reprint Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
    Rajiv Tandon
    Department of Psychiatry Adjunct, University of Florida, Gainesville, FL, USA
    Psychiatry Res 136:211-21. 2005
    ..35 days in the study and a decrease in CGI-I of 0.21 units. These results provide initial validation of the IAQ as a tool for evaluating antipsychotic response in patients with schizophrenia or schizoaffective disorder...
  11. pmc Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse
    Matcheri S Keshavan
    Department of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School, Boston, MA 02215, USA
    Schizophr Res 127:3-13. 2011
    ..The mouse may be the way to rescue the trapped elephant!..
  12. ncbi request reprint Practicing evidence-based psychiatry: 1. Applying a study's findings: The threats to validity approach
    Babu Rankupalli
    University of Florida, Gainesville, FL, USA
    Asian J Psychiatr 3:35-40. 2010
    ..We discuss the results of Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) in schizophrenia and consider the threats to the different forms of validity in CATIE...
  13. doi request reprint Practicing evidence-based psychiatry. 3. Interpreting treatment guidelines
    Ashley Clark
    University of Florida, Gainesville, FL, USA
    Asian J Psychiatr 4:304-8. 2011
    ....